348 related articles for article (PubMed ID: 22999245)
21. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Ayub M; Jin HK; Bae JS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
[TBL] [Abstract][Full Text] [Related]
22. The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: oxidative stress and the seesaw of cell survival and death.
Van Brocklyn JR; Williams JB
Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):26-36. PubMed ID: 22613819
[TBL] [Abstract][Full Text] [Related]
23. Sphingolipids in mammalian cell signalling.
Ohanian J; Ohanian V
Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
[TBL] [Abstract][Full Text] [Related]
24. [Sphingolipid and apoptosis].
Wang J; Hu XS; Shi JP
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):217-21. PubMed ID: 14628466
[TBL] [Abstract][Full Text] [Related]
25. The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy.
Ussher JR
Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):345-58. PubMed ID: 24552544
[TBL] [Abstract][Full Text] [Related]
26. Biochemical methods for quantifying sphingolipids: ceramide, sphingosine, sphingosine kinase-1 activity, and sphingosine-1-phosphate.
Brizuela L; Cuvillier O
Methods Mol Biol; 2012; 874():1-20. PubMed ID: 22528435
[TBL] [Abstract][Full Text] [Related]
27. Diabetes Mellitus and the Heart.
Schütt K; Müller-Wieland D; Marx N
Exp Clin Endocrinol Diabetes; 2019 Dec; 127(S 01):S102-S104. PubMed ID: 31860930
[No Abstract] [Full Text] [Related]
28. A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death.
Taha TA; Mullen TD; Obeid LM
Biochim Biophys Acta; 2006 Dec; 1758(12):2027-36. PubMed ID: 17161984
[TBL] [Abstract][Full Text] [Related]
29. Metabolomic profiling of sphingolipids in human glioma cell lines by liquid chromatography tandem mass spectrometry.
Sullards MC; Wang E; Peng Q; Merrill AH
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):789-97. PubMed ID: 14528916
[TBL] [Abstract][Full Text] [Related]
30. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
[TBL] [Abstract][Full Text] [Related]
31. Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics.
Maceyka M; Milstien S; Spiegel S
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):15-22. PubMed ID: 16099387
[TBL] [Abstract][Full Text] [Related]
32. Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes.
Brady EM; Cao TH; Moss AJ; Athithan L; Ayton SL; Redman E; Argyridou S; Graham-Brown MPM; Maxwell CB; Jones DJL; Ng L; Yates T; Davies MJ; McCann GP; Gulsin GS
BMC Cardiovasc Disord; 2024 Jan; 24(1):25. PubMed ID: 38172712
[TBL] [Abstract][Full Text] [Related]
33. Biophysical properties of sphingosine, ceramides and other simple sphingolipids.
Goñi FM; Sot J; Alonso A
Biochem Soc Trans; 2014 Oct; 42(5):1401-8. PubMed ID: 25233422
[TBL] [Abstract][Full Text] [Related]
34. High fat diet induced diabetic cardiomyopathy.
Dirkx E; Schwenk RW; Glatz JF; Luiken JJ; van Eys GJ
Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):219-25. PubMed ID: 21571515
[TBL] [Abstract][Full Text] [Related]
35. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come?
Radin NS
Eur J Biochem; 2001 Jan; 268(2):193-204. PubMed ID: 11168352
[TBL] [Abstract][Full Text] [Related]
36. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
37. High levels of sphingolipids in human breast cancer.
Nagahashi M; Tsuchida J; Moro K; Hasegawa M; Tatsuda K; Woelfel IA; Takabe K; Wakai T
J Surg Res; 2016 Aug; 204(2):435-444. PubMed ID: 27565080
[TBL] [Abstract][Full Text] [Related]
38. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
39. Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes.
Garbowska M; Łukaszuk B; Mikłosz A; Wróblewski I; Kurek K; Ostrowska L; Chabowski A; Żendzian-Piotrowska M; Zalewska A
J Cell Physiol; 2017 Oct; 232(10):2766-2775. PubMed ID: 28369933
[TBL] [Abstract][Full Text] [Related]
40. Nuclear sphingolipid metabolism.
Lucki NC; Sewer MB
Annu Rev Physiol; 2012; 74():131-51. PubMed ID: 21888508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
